Thyrocare Technologies Stock Screener | Share Price & Fundamental Analysis
THYROCARE
Healthcare Service Provider
Share Price NSE
₹399.45
▼
-8.25 (-2.02%)
Share Price BSE
₹398.00
▼
-6.55 (-1.62%)
Track Thyrocare Technologies share price live with TickJournal's free stock screener.
Analyze Thyrocare Technologies share price history trends and compare 52-week high low
levels.
Calculate THYROCARE stock fair value using fundamental analysis and view live share price charts.
Determine Thyrocare Technologies share intrinsic value and compare it with current THYROCARE share price.
Record your Thyrocare Technologies trades in TickJournal's free trading journal and track your portfolio performance.
Thyrocare Technologies Market Cap
₹6,475.49 Cr.
EPS (TTM)
₹17.13
Dividend Yield
1.73%
Debt to Equity
0.06
THYROCARE 52 Week High
₹1591.90
Thyrocare Technologies 52 Week Low
₹389.95
Operating Margin
26.00%
Profit Margin
13.93%
THYROCARE Revenue (TTM)
₹201.00
EBITDA
₹57.00
Net Income
₹28.00
Total Assets
₹693.00
Total Equity
₹547.00
Thyrocare Technologies Share Price History - Stock Screener Chart
Screen THYROCARE historical share price movements with interactive charts. Analyze price trends and patterns.
Thyrocare Technologies Company Profile - Fundamental Screener
Screen Thyrocare Technologies company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for THYROCARE shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE594H01019
Thyrocare Technologies Balance Sheet Screener
Screen THYROCARE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 | 410 |
| Current Assets | 338 | 279 | 273 | 270 | 240 | 152 | 136 | 142 | 150 | 134 |
| Fixed Assets | 297 | 306 | 294 | 285 | 253 | 269 | 294 | 299 | 259 | 259 |
| Liabilities | ||||||||||
| Total Liabilities | 693 | 644 | 633 | 608 | 546 | 471 | 475 | 479 | 438 | 410 |
| Current Liabilities | 24 | 26 | 20 | 17 | 23 | 23 | 19 | 15 | 12 | 13 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 547 | 528 | 535 | 527 | 427 | 367 | 435 | 443 | 408 | 366 |
| Share Capital | 53 | 53 | 53 | 53 | 53 | 53 | 53 | 54 | 54 | 54 |
| Reserves & Surplus | 439 | 440 | 463 | 474 | 374 | 314 | 382 | 390 | 354 | 312 |
Thyrocare Technologies Income Statement Screener - Profit & Revenue Analysis
Screen Thyrocare Technologies income statement and profit fundamentals.
Analyze THYROCARE quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Thyrocare Technologies share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201 | 220 | 198 | 192 | 170 | 180 | 161 | 158 | 138 | 151 | 136 | 140 | 131 | 137 | 129 |
| Expenses | 144 | 145 | 135 | 130 | 124 | 129 | 115 | 121 | 103 | 111 | 100 | 111 | 100 | 103 | 92 |
| EBITDA | 57 | 75 | 63 | 62 | 46 | 51 | 46 | 37 | 35 | 40 | 36 | 29 | 31 | 33 | 37 |
| Operating Profit % | 26.00% | 33.00% | 30.00% | 30.00% | 25.00% | 27.00% | 27.00% | 22.00% | 23.00% | 25.00% | 26.00% | 18.00% | 22.00% | 23.00% | 28.00% |
| Depreciation | 22 | 12 | 11 | 14 | 17 | 13 | 11 | 13 | 14 | 11 | 10 | 11 | 10 | 9 | 9 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 35 | 63 | 51 | 47 | 28 | 37 | 34 | 23 | 20 | 28 | 25 | 17 | 20 | 24 | 28 |
| Tax | 7 | 15 | 12 | 26 | 9 | 10 | 10 | 6 | 5 | 8 | 8 | 5 | 5 | 8 | 6 |
| Net Profit | 28 | 48 | 38 | 22 | 19 | 26 | 24 | 17 | 15 | 20 | 17 | 13 | 15 | 15 | 22 |
| EPS | 1.82 | 9.05 | 7.35 | 4.17 | 3.58 | 4.99 | 4.52 | 3.54 | 2.78 | 3.84 | 3.26 | 2.36 | 2.78 | 3.80 | 4.11 |
Thyrocare Technologies Cash Flow Screener - Liquidity Fundamentals
Screen THYROCARE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 191 | 168 | 129 | 113 | 115 | 168 | 100 | 107 | 90 | 68 |
| Investing Activities | -53 | -91 | -39 | -24 | -49 | 1 | -12 | -43 | -42 | -18 |
| Financing Activities | -130 | -85 | -86 | -89 | -62 | -165 | -94 | -64 | -49 | -45 |
| Net Cash Flow | 8 | -9 | 4 | 0 | 5 | 4 | -5 | 0 | -1 | 5 |
Thyrocare Technologies Shareholding Pattern Screener
See Thyrocare Technologies shareholding pattern with promoter, FII, and DII holdings.
Check Thyrocare Technologies promoter holding and ownership changes for THYROCARE on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 71.06% | 71.06% | 71.06% | 60.93% | 71.11% | 71.11% | 71.11% | 71.06% |
| FII Holding | 2.41% | 3.23% | 4.85% | 4.95% | 2.90% | 2.49% | 1.93% | 2.77% |
| DII Holding | 14.97% | 14.54% | 13.47% | 20.51% | 14.88% | 14.90% | 14.80% | 14.67% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.21% | 8.94% | 8.19% | 10.88% | 8.48% | 8.66% | 9.78% | 9.16% |
| Other Holding | 2.36% | 2.23% | 2.43% | 2.73% | 2.63% | 2.84% | 2.38% | 2.33% |
| Shareholder Count | 57,403 | 54,566 | 54,142 | 77,969 | 64,823 | 61,636 | 59,377 | 56,666 |
Thyrocare Technologies Share Dividend Screener - Share Yield Analysis
Check Thyrocare Technologies dividend history with payout and yield data.
View Thyrocare Technologies dividend details including ex-dates and amounts for THYROCARE stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹21.00 | 5.21% |
| 2024-March | ₹18.00 | 7.95% |
| 2023-March | ₹18.00 | 9.15% |
| 2022-March | ₹15.00 | 10.47% |
| 2021-March | ₹25.00 | 9.67% |
| 2020-March | ₹5.00 | 1.66% |
| 2019-March | ₹20.00 | 12.08% |
| 2018-March | ₹10.00 | 5.62% |
| 2017-March | ₹10.00 | 5.03% |
Thyrocare Technologies Stock Index Membership
See which indices include Thyrocare Technologies stock.
Check THYROCARE index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Thyrocare Technologies Market Events Screener - Corporate Actions
Get Thyrocare Technologies corporate actions including splits, bonuses, and buybacks.
Check Thyrocare Technologies stock events that may affect THYROCARE share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-01-28 | 2026-01-28 | Quarterly Result Announcement | NA | -4.81% |
| 2025-11-28 | 2025-11-28 | Bonus | 2:1 | -5.76% |
| 2025-10-24 | 2025-10-24 | Dividend | ₹ 7.00 /share | -0.66% |
| 2025-10-14 | 2025-10-14 | Quarterly Result Announcement | NA | 7.05% |
| 2025-07-31 | 2025-07-31 | Annual General Meeting | NA | 27.09% |
| 2025-07-25 | 2025-07-25 | Dividend | ₹ 21.00 /share | 68.16% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | 2.06% |
| 2025-04-23 | 2025-04-23 | Quarterly Result Announcement | NA | 13.10% |
| 2025-01-23 | 2025-01-23 | Quarterly Result Announcement | NA | -2.22% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | 7.33% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 8.95% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 18.00 /share | 42.02% |
| 2023-04-20 | 2023-04-20 | Dividend | ₹ 18.00 /share | 13.04% |
| 2022-05-11 | 2022-05-12 | Dividend | ₹ 15.00 /share | -9.36% |
| 2021-06-17 | 2021-06-19 | Dividend | ₹ 15.00 /share | 21.60% |
Thyrocare Technologies Competitors Screener - Peer Comparison
Screen THYROCARE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 23,806 | 43.99 | 2,555 | 11.28% | 492 | 48.89 |
| Vijaya Diagnostic Centre | 10,364 | 66.85 | 700 | 23.06% | 144 | 54.52 |
| Metropolis Healthcare | 10,041 | 59.56 | 1,346 | 10.64% | 146 | 51.03 |
| Thyrocare Technologies | 6,475 | 47.28 | 702 | 20.80% | 91 | 41.10 |
| Nephrocare Health Services | 5,579 | 80.72 | 770 | 33.97% | 67 | 61.79 |
| Krsnaa Diagnostics | 2,154 | 26.93 | 743 | 16.70% | 78 | 32.82 |
| One Global Service Provider | 1,531 | 33.25 | 148 | 134.60% | 19 | 75.94 |
| Suraksha Diagnostic | 1,483 | 45.68 | 256 | 15.11% | 31 | 60.11 |
| 3B BlackBio DX | 1,361 | 23.52 | 112 | 28.72% | 48 | 50.23 |
| Sastasundar Ventures | 945 | 32.12 | 1,171 | -18.47% | -134 | 47.24 |
Thyrocare Technologies Company Announcements - News Screener
Screen THYROCARE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2026-01-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015 | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2026-01-28 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2026-01-28 | Financial Results For The Quarter And Nine Months Ended December 31 2025. | View |
| 2026-01-28 | Board Meeting Outcome for Outcome Of The Board Meeting Held On January 28 2026 | View |
| 2026-01-27 | Press Release - Thyrocare Onboards Madhuri Dixit As The Brand Ambassador To Inspire Health And Well-Being Across India | View |
| 2026-01-22 | Intimation Of Receipt Of Awards | View |
| 2026-01-20 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2026-01-20 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31 2025 | View |
| 2026-01-17 | Change Of Name Of M S K A & Associates Upon Conversion Of Firm Into LLP | View |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-05 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-23 | Closure of Trading Window | View |
| 2025-12-18 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-12-05 | Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011. | View |
| 2025-12-05 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | View |
| 2025-12-04 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |